GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,453,000 | -0.1% | 33,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,454,000 | -1.2% | 33,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,472,000 | +18.9% | 33,400 | +3.1% | 0.00% | +100.0% |
| Q3 2021 | $1,238,000 | -4.0% | 32,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,290,000 | +11.6% | 32,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,156,000 | -10.8% | 32,400 | -8.0% | 0.00% | -50.0% |
| Q4 2020 | $1,296,000 | -2.2% | 35,225 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,325,000 | -5.1% | 35,225 | +2.9% | 0.00% | 0.0% |
| Q2 2020 | $1,396,000 | +4.6% | 34,225 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,334,000 | -26.1% | 35,225 | -8.3% | 0.00% | -33.3% |
| Q4 2019 | $1,805,000 | +8.4% | 38,425 | -1.5% | 0.00% | 0.0% |
| Q3 2019 | $1,665,000 | +6.7% | 39,014 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,561,000 | -4.2% | 39,014 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,630,000 | +2.1% | 39,014 | -6.6% | 0.00% | 0.0% |
| Q4 2018 | $1,596,000 | -0.1% | 41,774 | +5.0% | 0.00% | 0.0% |
| Q3 2018 | $1,597,000 | -0.4% | 39,774 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,603,000 | +3.2% | 39,774 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,553,000 | -15.0% | 39,774 | -22.8% | 0.00% | 0.0% |
| Q4 2017 | $1,827,000 | -13.2% | 51,546 | -0.6% | 0.00% | -25.0% |
| Q3 2017 | $2,105,000 | -5.0% | 51,859 | +0.9% | 0.00% | 0.0% |
| Q2 2017 | $2,215,000 | +30.1% | 51,377 | +27.3% | 0.00% | +33.3% |
| Q1 2017 | $1,702,000 | +8.1% | 40,374 | -1.2% | 0.00% | 0.0% |
| Q4 2016 | $1,574,000 | -69.9% | 40,874 | -66.2% | 0.00% | -70.0% |
| Q3 2016 | $5,221,000 | -0.5% | 121,074 | 0.0% | 0.01% | -9.1% |
| Q2 2016 | $5,247,000 | +6.9% | 121,074 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $4,909,000 | +0.5% | 121,074 | -0.0% | 0.01% | 0.0% |
| Q4 2015 | $4,886,000 | +5.0% | 121,109 | +0.0% | 0.01% | 0.0% |
| Q3 2015 | $4,655,000 | -7.7% | 121,074 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $5,042,000 | -9.8% | 121,074 | -0.0% | 0.01% | -8.3% |
| Q1 2015 | $5,589,000 | +9.4% | 121,114 | +1.3% | 0.01% | +9.1% |
| Q4 2014 | $5,110,000 | -7.1% | 119,574 | -0.1% | 0.01% | -8.3% |
| Q3 2014 | $5,499,000 | -14.7% | 119,635 | -0.8% | 0.01% | -7.7% |
| Q2 2014 | $6,448,000 | -0.2% | 120,574 | -0.2% | 0.01% | -7.1% |
| Q1 2014 | $6,458,000 | +0.1% | 120,874 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $6,453,000 | +6.4% | 120,874 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $6,064,000 | +0.3% | 120,874 | -0.1% | 0.01% | 0.0% |
| Q2 2013 | $6,045,000 | – | 120,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |